Trump is 'open' to working with Democrats at the SEC and CFTC, giving a glimmer of hope for the Senate's crypto bill.

As Eli Lilly and Novo Nordisk scramble to bring an oral glucagon-like peptide 1 (GLP-1) receptor agonist to market for obesity, much smaller potential rival Structure Therapeutics spotlighted positive ...